New 52-Week High: SmallCap Stock Strides Pharma Jumps Over 11% On USFDA Approval
Bengaluru-based drugmaker, Strides Pharma Science witnessed an impressive buying on Friday as the smallcap stock jumped over 11% to touch a new 52-week high. The strong bulls appeared after the pharma company's step-down wholly owned subsidiary, Strides Pharma Global Pte. Limited, ...
